1 / 75

Bowel Disorders

Bowel Disorders. Presnted by Shiva Golian , D.O. Disclosures. None. Objectives. Identify, diagnose and treat irritable bowel syndrome Identify, diagnose and treat fecal incontinence Identify, diagnose and treat pruritis ani. Irritable Bowel Syndrome.

reia
Download Presentation

Bowel Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Bowel Disorders Presnted by Shiva Golian, D.O.

  2. Disclosures • None

  3. Objectives • Identify, diagnose and treat irritable bowel syndrome • Identify, diagnose and treat fecal incontinence • Identify, diagnose and treat pruritisani

  4. Irritable Bowel Syndrome • Syndrome: group of signs or symptoms that characterize a specific disorder • Type of functional GI disorder: chronic disorders of the GI tract in which an organic or structural lesion responsible for symptom development cannot be identified

  5. Irritable Bowel Syndrome

  6. IBSPrevalence and Epidemiology • Prevalence in North America: 10-15% • 2:1 female prevalence • Only 15% of those affected seek medical attention • Comprises 25-50% of all referrals to the gastroenterologist • After the common cold, second highest cause of work absenteeism • Peak prevalence: 3rdand 4th decades • Decreased prevalence in 6th and 7th decades • Dx should be made cautiously after age 60

  7. IBS Etiology

  8. IBSPathogenesis • Altered Gastrointestinal Motility • No predominant pattern: clustered contractions vs prolonged contractions • Exaggeration of the normal gut motility

  9. IBSPathogenesis • Visceral Hypersensitivity • Distention • Balloon distention sensed at lower volumes • Rectal distention increased cerebral cortical activity • Bloating • Increased abdominal girth • Impaired transit of intestinal gas loads

  10. IBSPathogenesis • Intestinal Inflammation • Some studies show an increased number of colonic lymphocytes, mast cells and plasma proinflammatory interleukins in those with IBS

  11. IBSPathogenesis • Postinfectious • Associated with bacterial, protozoal, helminthic and viral infections • Thabane et al (meta-analysis of 18 studies) • Incidence of postinfectious IBS is 10% • Odds of developing IBS increase sixfold after acute GI infection • Risk factors: young age, prolonged fever, anxiety, depression • Causes of postinfectious bowel symptoms • Malabsorption: idiopathic bile acid malabsorption • Increase in enteroendocrine cells/lymphocytes: increased serotonin levels causes increased GI motility and visceral hypersensitivity • Antibiotic use

  12. IBSPathogenesis • Change in the fecal microflora • Is there a role in probiotic use? Need more information

  13. IBSPathogenesis • Small intestinal Bacterial Overgrowth (SIBO) • Pimental et al • 78% of 202 pts that met Rome I criteria for IBS had abnormal lactulose breath test suggestive of bacterial overgrowth • Very exciting news: this means that IBS can be cured with antibiotics • Unfortunately, more recent studies have failed to find any association between IBS and SIBO

  14. IBSPathogenesis • Food Sensitivity • Food allergy: studies have been conflicting • Carbohydrate malabsorption: need more investigation • Gluten sensitivity: • Those without villous atrophy, presence of serum IgGantigliadin antibodies and expression of HLA-DQ2 may have a good response to gluten free diet • Make sure to confirm the absence of celiac disease

  15. IBSPathogenesis • Genetics • Many studies with twins showing concordance rates ranging from 2-22% • One study found that having a parent with IBS was a greater independent predictor of IBS than having an affected twin • Thus it could be due to social learning • Genotyping studies • Perhaps an association with IBS and polymorphisms of serotonin transporter gene

  16. IBSPathogenesis • Psychosocial Dysfunction • More lifetime and daily stressful events than control groups • Those with IBS have increased anxiety, depression, phobias and somatization • Positive association between IBS and abuse • Fukudo et al • Administration of corticotropin releasing factor (CRF – mediator of stress response) increases abdominal pain and colonic motility in IBS pts

  17. IBS Diagnostic Criteria • Manning Criteria • Pain relieved with defecation • More frequent stools at the onset of pain • Looser stools at the onset of pain • Visible abdominal distention • Passage of mucus • Sensation of incomplete evacuation

  18. IBS Diagnostic Criteria • Rome III criteria • Recurrent abdominal pain or discomfort at least 3 days per month in the last 3 months associated with 2 or more of the following: • Improvement with defecation • Onset associated with a change in frequency of stool • Onset associated with a change in form (appearance) of stool • Symptom onset at least 6 months prior to diagnosis • **Developed for clinical investigation; no emphasis on postprandial urgency, abdominal pain, diarrhea

  19. IBSSubtypes • IBS with constipation (IBS-C): hard or lumpy stools >/= 25% or loose/watery stools <25% of BMs • IBS with diarrhea (IBS-D): loose or watery stools >/=25% or hard/lumpy stools <5% of BMs • Mixed IBS (IBS-M): hard/lumpy stools >/=25% or loose/watery stools >/=25% of BMs (most common group) • Unsubtyped IBS: insufficient abnormality of stool consistency to meet the above subtypes

  20. DiagnosisHistory • 2 most common complaints • Abdominal pain • Required for diagnosis of IBS • Should be temporally related to defecation in some way • Location of pain varies from person to person, but is consistent over time in the individual • Altered bowel habits • But also remember bloating • Remember – these pts have an altered tolerance to normal amounts of distention

  21. DiagnosisHistory • Be careful of alarm symptoms or “red flags” • Rectal bleeding • Nocturnal/progressive abdominal pain • Weight loss • Ask about travel history

  22. DiagnosisPhysical • PE generally WNL • Abdominal exam • Tenderness – generally the LLQ • Should not have any rebound or guarding

  23. Diagnosis • Good history and physical exam • Routine labwork (normal in IBS pts) • CBC • Chemistries • ESR • Stool samples for those with diarrhea • TSH for those with constipation • History with chronic symptoms, normal PE, normal labwork: accuracy of diagnosis is 95-97%

  24. Diagnosis • Colonoscopy • Caucasians 50 or older • African Americans 45 or older • Strong family history of colorectal cancer or inflammatory bowel disease • Those with anemia • Those with stool WBCs • Those with alarm symptoms • Those with abnormal labwork • Diagnosis of exclusion

  25. Treatment • No cure • Treatment focused on symptom relief • Must have a good therapeutic relationship • Kaptchuck et al • Pts with positive relationship with their healthcare provider have significantly more improvement • Patient education • Chronicity of syndrome • Normal life span

  26. Treatment • Dietary • Efficacy of dietary modification not well established • Lactose • Exclusion of gas-producing foods • Food allergy testing: not well studied • Gluten sensitivity • Carbohydrate malabsorption: not enough large studies • Fiber: efficacy not proven

  27. Treatment • Physical activity: potential benefit • Psychosocial therapies • May be beneficial in those with IBS symptoms associated with stressors • Benefits are controversial

  28. Treatment • Pharmacotherapy • Antispasmodic agents • Dicyclomine (Bentyl) • Hyoscyamine (Levsin, Levbid, NuLev) • *Chlordiazepoxide/clidinium (Librax) • * Phenobarbital/hyoscyamine/atropine/scopolamine (Donnatal)

  29. Treatment • Pharmacotherapy • Antidepressants • May be beneficial in those with neuropathic pain • TCAs have anticholinergic properties which help to slow intestinal transit time (helps with IBS-D) • Improvement in pain with TCAs occurs at lower doses than doses used for treatment of depression • TCAs to try: Amitriptyline (Elavil), imipramine (Tofranil), nortriptyline (Pamelor), desipramine (Norpramin) • Be careful with those with IBS-C • Other meds: paroxetine (Paxil), fluoxetine (Prozac), sertraline (Zoloft)

  30. Treatment • Pharmacotherapy • Antidiarrheal agents • Loperamide (Imodium) – effective for tx of diarrhea, but not for tx of global IBS symptoms or abdominal pain • Alosetron (Lotronex) • 5-HT3 receptor antagonist • Used in females with IBS-D • Complications: ischemic colitis, severe constipation • FDA has brought this back under tight control

  31. Treatment • Pharmacotherapy • Tegaserod (Zelnorm) • 5-HT4 receptor agonist • Used in IBS-C • Removed from market d/t cardiovascular side-effects • Lubiprostone (Amitiza) • Locally acting chloride channel activator • Best to use with for those with IBS with severe constipation where other approaches have failed • Used in IBS-C

  32. Treatment • Pharmacotherapy • Linaclotide (Linzess) • Guanylatecyclaseagonist – stimulates intestinal fluid secretion and transit • Used for IBS-C • Antibiotics • Rifaximin – a nonabsorbable antibiotic • Improvement in bloating, abd pain, or altered bowel habits • Used in IBS without constipation • Benefits may be due to suppression of gas producing bacteria in colon

  33. Treatment • Alternative therapy • Peppermint oil • Probiotics • Acupuncture • Enzyme supplementation • Hypnotherapy

  34. Fecal Incontinence

  35. Fecal IncontinenceBackground • In 1988 • Cost of adult diapers thought to exceed $400 million annually • Second leading cause of nursing home placement • Definition • Continuous/recurrent uncontrolled passage of feces (>10ml) for at least 1 month in someone > 3-4 yrs old

  36. Fecal IncontinenceEpidemiology • Varies greatly depending on age, definition, setting: 1-24% • This may be an underestimation • Occurs in about 47% of nursing home residents

  37. Fecal IncontinenceRisk Factors • Increasing age • Occurs in 15% of those >/= 70 • Poor general health • Physical limitations • COPD • IBS • Urinary incontinence • Chronic diarrhea • In women: depression and white race

  38. Fecal Incontinence • Anatomic considerations

  39. Fecal Incontinence

  40. Fecal IncontinencePathophysiology • Dysfunction of anal sphincters • Abnormal rectal compliance • Decreased rectal sensation • Combination of the above

  41. Fecal IncontinencePathophysiology • Dysfunction of anal sphincters • Vaginal delivery • Anal sphincter tears • Trauma to pudendal nerve: may cause incontinence years after delivery • Risks: • Forceps • High birth weight infant • Long second stage of labor • Occipitoposterior presentation of fetus

  42. Fecal IncontinencePathophysiology • Dysfunction of anal sphincters • Surgical trauma • Anal fistula • Hemorrhoidectomy • After injection of botulinum toxin • Diabetes mellitus • Reduced internal anal sphincter resting pressure • Can be due to autonomic neuropathy

  43. Fecal IncontinencePathophysiology • Decreased rectal compliance • Ability of rectum to store fecal debris is reduced • Leads to increased frequency and urgency • Leads to incontinence even if sphincter function is normal • Common conditions • Ulcerative colitis • Radiation proctitis

  44. Fecal IncontinencePathophysiology • Impaired rectal sensation • DM • MS • Dementia • Meningomyelocele • Spinal cord injury

  45. Fecal IncontinencePathophysiology • Fecal impaction • Elderly • Constant inhibition of internal anal sphincter • Overflow incontinence

  46. Fecal Incontinence • History • Differentiate true incontinence from frequency and urgency • History of: • Prior vaginal delivery • Anorectal surgery • Pelvic irradiation • Diabetes • Neurologic disease • Do symptoms occur with a background of diarrhea?

  47. Fecal Incontinence • Physical exam • Appropriate inspection of the perianal area • Fistula, prolapsing hemorrhoids, rectal prolapse • Anocutaneous reflex (anal wink sign) • Absence suggests nerve damage • Digital Rectal Exam • Mass, fecal impaction • Pt should be instructed to bear down and then squeeze against the finger

  48. Fecal IncontinenceDiagnostic Procedures • Anorectalmanometry • Measures pressures • Decreased resting pressure suggests isolated IAS dysfunction • Decreased squeeze pressure suggests isolated EAS dysfunction

  49. Fecal IncontinenceDiagnostic Procedures • Endorectal ultrasound/MRI • Good for identifying structural abnormalities of the anal sphincters, rectal wall, puborectalis muscle • Ultrasound much more economical • Findings correlate well with manometric findings

  50. Fecal IncontinenceDiagnostic Procedures • Defecography • Barium paste is instilled into rectum • Pt is then seated on a radiolucent commode and films are taken at rest and during straining and defecation

More Related